Sökning: "reimbursement"
Visar resultat 6 - 10 av 38 avhandlingar innehållade ordet reimbursement.
6. Promises and pitfalls of value-based reimbursement in healthcare : A mixed method health economic approach
Sammanfattning : Financial incentives can be an effective tool to influence behaviour in almost any context and healthcare is no exception. The healthcare market is, however complex, characterised by uncertainty, information asymmetry and multiple agency connections. The reach and limits of financial incentives in healthcare has been widely debated for decades. LÄS MER
7. Investigating practice variation in a changing primary care. A multilevel perspective on The Skaraborg Primary Care Database
Sammanfattning : Background and Aims: Differences in the clinical care of patients have been explained through the concept of practice variation, that is, the occurrence of established local medical procedures that varies between geographic areas. The primary measures introduced to eliminate undesirable differences in medical care are the introduction of medical guidelines and economical incentives that rewards the desired behaviour. LÄS MER
8. Do Financial Incentives Make a Difference? : A Comparative Study of the Effects of Performance-Based Reimbursement in Swedish Health Care
Sammanfattning : Financial incentives have become important in health care all over the world. This thesis compares one council implementing a new payment system based on performance based reimbursement (PBR) with ten councils retaining an annual budget system. LÄS MER
9. The role of economic evaluations in health care decision making
Sammanfattning : Increasing health care expenditures, a rapid introduction of new medical technologies and a need for cost containment policies in most countries during the last decades have led to a growing interest in information from economic evaluations for decision making about resource allocation in health care. Economic evaluations can provide valuable information in many types of decision making, e. LÄS MER
10. Healthcare Priority Setting and Rare Diseases : What Matters When Reimbursing Orphan Drugs
Sammanfattning : The rarity of a disease can give rise to challenges that differ from conventional diseases. For example, rarity hampers research and development of new drugs, and patients with severe, rare diseases have limited access to qualified treatments. When drugs are available, clinical evidence has higher uncertainty and the drugs can be very expensive. LÄS MER
